Publication: Infliximab therapy in an infant with Netherton Syndrome
dc.contributor.author | Çiçek, Fatih | |
dc.contributor.author | Çekiç, Şükrü | |
dc.contributor.author | Kılıç, Sara Şebnem | |
dc.contributor.buuauthor | ÇİÇEK, FATİH | |
dc.contributor.buuauthor | ÇEKİÇ, ŞÜKRÜ | |
dc.contributor.buuauthor | KILIÇ GÜLTEKİN, SARA ŞEBNEM | |
dc.contributor.department | Bursa Uludağ Üniversitesi/Tıp Fakültesi/Pediatrik İmmünoloji Anabilim Dalı. | |
dc.contributor.orcid | 0000-0002-9574-1842 | |
dc.contributor.orcid | 0000-0001-8571-2581 | |
dc.contributor.orcid | 0000-0001-7348-7081 | |
dc.contributor.researcherid | AAH-1658-2021 | |
dc.contributor.researcherid | JKI-5906-2023 | |
dc.contributor.researcherid | L-1933-2017 | |
dc.date.accessioned | 2024-06-12T07:08:17Z | |
dc.date.available | 2024-06-12T07:08:17Z | |
dc.date.issued | 2021-04-22 | |
dc.description.abstract | We present a patient with Netherton syndrome and severe skin manifestations treated with infliximab. By 6 months of age, the child had intractable pruritus, scaling, dry skin, and generalized eczematous lesions resistant to conventional therapies for atopic dermatitis. Clinical improvement was observed following the third infusion of infliximab, and by 12 months of age, the skin lesions completely resolved. Infliximab is a promising option for the management of skin inflammation in Netherton syndrome, even in infants. | |
dc.identifier.doi | 10.1111/pde.14590 | |
dc.identifier.eissn | 1525-1470 | |
dc.identifier.endpage | 716 | |
dc.identifier.issn | 0736-8046 | |
dc.identifier.issue | 3 | |
dc.identifier.startpage | 714 | |
dc.identifier.uri | https://doi.org/10.1111/pde.14590 | |
dc.identifier.uri | https://onlinelibrary.wiley.com/doi/10.1111/pde.14590 | |
dc.identifier.uri | https://hdl.handle.net/11452/42039 | |
dc.identifier.volume | 38 | |
dc.identifier.wos | 000642325600001 | |
dc.indexed.wos | WOS.SCI | |
dc.language.iso | en | |
dc.publisher | Wiley | |
dc.relation.journal | Pediatric Dermatology | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | |
dc.rights | info:eu-repo/semantics/closedAccess | |
dc.subject | Childhood | |
dc.subject | Ichthyosis | |
dc.subject | Nfliximab | |
dc.subject | Netherton syndrome | |
dc.subject | Tumor necrosis factor‐ | |
dc.subject | Dermatology | |
dc.subject | Pediatrics | |
dc.title | Infliximab therapy in an infant with Netherton Syndrome | |
dc.type | Article | |
dspace.entity.type | Publication | |
relation.isAuthorOfPublication | 05aab409-83f1-4f96-89f0-35f66a87fb83 | |
relation.isAuthorOfPublication | ca52bf41-6be5-42a5-b2c5-f219305eba24 | |
relation.isAuthorOfPublication | cb4f5525-5861-44f7-8234-fc2b376a934d | |
relation.isAuthorOfPublication.latestForDiscovery | 05aab409-83f1-4f96-89f0-35f66a87fb83 |